Winter 2017/18 Teasers
Drug Discovery World
Emerging drug discovery alliance models
By Dr Swati Prasad, Mary Louise Bell & Dr Charles McOsker

The current environment for early-stage drug discovery and development is fluid and the probability of success continues to be challenging.

Advancing an idea from an academic or basic research setting into a therapeutic product that benefits patients is time- and capital-intensive, sometimes inefficient and – frustratingly often – unsuccessful. This reality has led entities in the early drug discovery and development ecosystem to utilise new alliance-based partnership models to increase their chances of success....

You just need to REGISTER - its FREE - to read the rest of this article straight away.